聚砜膜生物反应器实验系统对重肝患者血浆的影响

目的：了解聚砜膜生物反应器实验系统对重肝患者血浆的影响,探索聚砜膜中空纤维反应器作为生物人工肝反应器的可行性。方法：用磁力搅动法将分离的新生实验小型猪肝细胞进行球形体培养,接种到聚砜膜中空纤维反应器外腔,观察聚砜膜生物反应器实验系统对重肝患者血浆的血氨、胆红素、凝血酶原时间、TNF-α、TGF-β1的影响。结果：该实验系统能降低重肝患者血浆的血氨、胆红素,缩短凝血酶原时间,降低TNF-α、TGF-β1水平。结论：聚砜膜生物反应器实验系统能够清除重肝患者血浆中的小分子有毒物质,补充有益成分,降低细胞因子水平。     

Characterisation of Flavour Attributes in Egg White Protein Using HS-GC-IMS Combined with E-Nose and E-Tongue: Effect of High-Voltage Cold Plasma Treatment Time

Egg white protein (EWP) is susceptible to denaturation and coagulation when exposed to high temperatures, adversely affecting its flavour, thereby influencing consumers’ decisions. Here, we employ high-voltage cold plasma (HVCP) as a novel nonthermal technique to investigate its influence on the EWP’s flavour attributes using E-nose, E-tongue, and headspace gas-chromatography-ion-mobilisation spectrometry (HS-GC-IMS) due to their rapidness and high sensitivity in identifying flavour fingerprints in foods. The EWP was investigated at 0, 60, 120, 180, 240, and 300 s of HVCP treatment time. The results revealed that HVCP significantly influences the odour and taste attributes of the EWP across all treatments, with a more significant influence at 60 and 120 s of HVCP treatment. Principal component analyses of the E-nose and E-tongue clearly distinguish the odour and taste sensors’ responses. The HS-GC-IMS analysis identified 65 volatile compounds across the treatments. The volatile compounds’ concentrations increased as the HVCP treatment time was increased from 0 to 300 s. The significant compounds contributing to EWP characterisation include heptanal, ethylbenzene, ethanol, acetic acid, nonanal, heptacosane, 5-octadecanal, decanal, p-xylene, and octanal. Thus, this study shows that HVCP could be utilised to modify and improve the EWP flavour attributes.     

Development and Validation of a Reliable UHPLC-MS/MS Method for Simultaneous Quantification of Macrocyclic Lactones in Bovine Plasma

A fast, accurate and reliable ultra-high performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS) method was developed for simultaneous quantification of ivermectin (IVER), doramectin (DORA), and moxidectin (MOXI) in bovine plasma. A priority for sample preparation was the eradication of possible infectious diseases to avoid travel restrictions. The sample preparation was based on protein precipitation using 1% formic acid in acetonitrile, followed by Ostro^® 96-well plate pass-through sample clean-up. The simple and straightforward procedure, along with the short analysis time, makes the current method unique and suitable for a large set of sample analyses per day for PK studies. Chromatographic separation was performed using an Acquity UPLC HSS-T3 column, with 0.01% acetic acid in water and methanol, on an Acquity H-Class ultra-high performance liquid chromatograph (UHPLC) system. The MS/MS instrument was a Xevo TQ-S^® mass spectrometer, operating in the positive electrospray ionization mode and two multiple reaction monitoring (MRM) transitions were monitored per component. The MRM transitions of m/z 897.50 > 753.4 for IVER, m/z 921.70 > 777.40 for DORA and m/z 640.40 > 123.10 for MOXI were used for quantification. The method validation was performed using matrix-matched calibration curves in a concentration range of 1 to 500 ng/mL. Calibration curves fitted a quadratic regression model with 1/x2 weighting (r ≥ 0.998 and GoF ≤ 4.85%). Limits of quantification (LOQ) values of 1 ng/mL were obtained for all the analytes, while the limits of detection (LOD) were 0.02 ng/mL for IVER, 0.03 ng/mL for DORA, and 0.58 ng/mL for MOXI. The results of within-day (RSD < 6.50%) and between-day (RSD < 8.10%) precision and accuracies fell within acceptance ranges. No carry-over and no peak were detected in the UHPLC-MS/MS chromatogram of blank samples showing good specificity of the method. The applicability of the developed method was proved by an analysis of the field PK samples.     

Dielectric Properties of Colossal-Dielectric-Constant Na1/2La1/2Cu3Ti4O12 Ceramics Prepared by Spark Plasma Sintering

In the current study, we report on the dielectric behavior of colossal-dielectric-constant Na_1/2La_1/2Cu₃Ti₄O₁₂ (NLCTO) ceramics prepared by mechanochemical synthesis and spark plasma sintering (SPS) at 850 °C, 900 °C, and 925 °C for 10 min. X-ray powder diffraction analysis showed that all the ceramics have a cubic phase. Scanning electron microscope observations revealed an increase in the average grain size from 175 to 300 nm with an increase in the sintering temperature. SPS NLCTO ceramics showed a room-temperature colossal dielectric constant (>10³) and a comparatively high dielectric loss (>0.1) over most of the studied frequency range (1 Hz–40 MHz). Two relaxation peaks were observed in the spectra of the electrical modulus and attributed to the response of grain and grain boundary. According to the Nyquist plots of complex impedance, the SPS NLCTO ceramics have semiconductor grains surrounded by electrically resistive grain boundaries. The colossal dielectric constant of SPS NLCTO ceramics was attributed to the internal barrier layer capacitance (IBLC) effect. The high dielectric loss is thought to be due to the low resistivity of the grain boundary of SPS NLCTO.     

Effects of nuclear charge fluctuations on dilepton photoproduction

Fluctuations of dilepton production from two photon interactions γγ→l~+l~- are studied in semicentral and peripheral nuclear collisions.Based on the Weizsacker-Williams approach,electromagnetic(EM) fields generated by moving nuclear charges are approximated as quasi-real photons.As fluctuating EM fields in each collision event are hard to be measured directly in experiments due to its short lifetime,we study the dilepton photoproduction with fluctuating EM fields,which are crucial for the EM fields induced chiral and charged particle evolutions,and calculate the relative standard deviation of the dilepton mass spectrum with the event-by-event fluctuating nuclear charge distributions.This fluctuation effect becomes smaller in more peripheral collisions where the shift of proton positions is implicit for EM fields outside the nucleus.The uncertainty of effective impact parameter △b on the standard deviation is also studied,and its effect is around one-third of the effect of nuclear charge fluctuations when △b is taken as～1 fm.     

Experimental review of the ϒ(1S, 2S, 3S) physics at e+e− colliders and the LHC

The three lowest-lying \mathrm{\Upsilon } states, i.e., \mathrm{\Upsilon }(1S), \mathrm{\Upsilon }(2S), and \mathrm{\Upsilon }(3S), composed of bb¯ pairs and below the BB ¯ threshold, provide a good platform for the researches of hadronic physics and physics beyond the Standard Model. They can be produced directly in e⁺e⁻ colliding experiments, such as CLEO, Babar, and Belle, with low continuum backgrounds. In these experiments, many measurements of the exclusive \mathrm{\Upsilon }(1S) and \mathrm{\Upsilon }(2S) decays into light hadrons, which shed light on the “80% rule” for the Okubo–Zweig–Iizuka suppressed decays in the bottomonium sector, were carried out. Meanwhile, many studies of the charmonium and bottomonium productions in \mathrm{\Upsilon }(1S, 2S, 3S) decays were performed, to distinguish different Quantum Chromodynamics (QCD) models. Besides, exotic states and new physics were also extensively explored in \mathrm{\Upsilon }(1S, 2S, 3S) decays at CLEO, BaBar, and Belle. The \mathrm{\Upsilon }(1S, 2S, 3S) states can also be produced in pp collisions and in collisions involving heavy ions. The precision measurements of their cross sections and polarizations at the large hadron collider (LHC), especially in the CMS, ATLAS, and LHCb experiments, help to understandΥproduction mechanisms in pp collisions. The observation of the sequentialΥsuppression in heavy ion collisions at CMS, LHCb, and ALICE is of great importance for verifying the quark–gluon plasma predicted by QCD. In this article, we review the experimental results on \mathrm{\Upsilon }(1S, 2S, 3S) at e⁺e⁻ colliders and the LHC, and summarize their prospects at Belle II and the LHC.     

Partially crystallized Pd nanoparticles decorated TiO2 prepared by atmospheric-pressure cold plasma and its enhanced photocatalytic performance

TiO2 decorated with partially crystallized Pd nanoparticles （Pd/TiO2-P） was successfully prepared by atmospheric-pressure dielectric barrier discharge cold plasma. The XRD and XPS analyses proved that Pd ions were reduced to partially crystallized metallic Pd nanoparticles in Pd/TiO2-P. The XPS spectra also indicated that an enhanced metal-support interaction was formed due to the existence of partially crystallized Pd nanoparticles with lower coordination number in Pd/TiO2-P. Photocatalytic activity of Pd/TiO2-P was much higher than that of TiO2 samples decorated with well crystallized Pd nanoparticles.     

低温等离子体与MnO_x/γ-Al_2O_3协同催化降解正己醛

研究了在低温等离子体和催化剂共同作用下低浓度正己醛的降解反应.结果表明,等离子体与γ-Al2O3之间产生了很好的催化协同作用,在低放电功率(2.8W)和低温(80℃)下,干燥空气气氛中,γ-Al2O3对0.12%正己醛的去除率为87.1%;当γ-Al2O3负载7.5%MnOx后,正己醛去除率达到96.5%,其效果与Pt/γ-Al2O3相当.7.5%MnOx/γ-Al2O3在实验条件下连续使用50h,其催化活性未见下降.     

Determination of sulfur and selected trace elements in metallothionein-like proteins using capillary electrophoresis hyphenated to inductively coupled plasma mass spectrometry with an octopole reaction cell

The determination of sulfur in biologically relevant samples such as metalloproteins is described. The analytical methodology used is based on robust on-line coupling between capillary electrophoresis (CE) and octopole reaction cell inductively-coupled plasma mass spectrometry (ORC–ICP–MS). Polyatomic ions that form in the plasma and interfere with the determination of S at mass 32 are minimised by addition of xenon to the collision cell. The method has been applied to the separation and simultaneous element-specific detection of sulfur, cadmium, copper, and zinc in commercially available metallothionein preparations (MT) and metallothionein-like proteins (MLP) extracted from liver samples of bream (Abramis brama L.) caught in the river Elbe, Germany. Instrumental detection limits have been calculated according to the German standard procedure DIN 32645 for the determination of sulfur and some simultaneously measured trace elements in aqueous solution. For sulfur detection limits down to 1.3 g L^–1 (³⁴S) and 3.2 g L^–1 (³²S) were derived. For the other trace elements determined simultaneously detection limits ranging from 300 ng L^–1 (⁵⁸Ni) to 500 ng L^–1 (⁶⁶Zn, ⁵⁵Mn) were achieved. For quantification of sulfur and cadmium in a commercially available MT preparation under hyphenated conditions the use of external calibration is suggested. Finally, the need for proper sample-preparation technique will be discussed.     

Simple method for the determination of rosiglitazone in human plasma using a commercially available internal standard

To the best of our knowledge, bioanalytical methods to determine rosiglitazone in human plasma reported in literature use internal standards that are not commercially available. Our purpose was to develop a simple method for the determination of rosiglitazone in plasma employing a commercially available internal standard (IS). After the addition of celecoxib (IS), plasma (0.25 mL) samples were extracted into ethyl acetate. The residue after evaporation of the organic layer was dissolved in 750 microL of mobile phase and 50 microL was injected on to HPLC. The separation was achieved using a Hichrom KR 100, 250 x 4.6 mm C(18) with a mobile phase composition potassium dihydrogen phosphate buffer (0.01 m, pH 6.5):acetonitrile:methanol (40:50:10, v/v/v). The flow-rate of the mobile phase was set at 1 mL/min. The column eluate was monitored by fluorescence detector set at an excitation wavelength of 247 nm and emission wavelength of 367 nm. Linear relationships (r(2) > 0.99) were observed between the peak area ratio rosiglitazone to IS vs rosiglitazone concentrations across the concentration range 5-1000 ng/mL. The intra-run precision (%RSD) and accuracy (%Dev) in the measurement of rosiglitazone were <+/-10.69 and <-12.35%, respectively across the QC levels (50-1000 ng/mL). The extraction efficiency was >80% for both rosiglitazone and IS from human plasma. The lower limit of quantitation of the assay was 5 ng/mL. In summary, the methodology for rosiglitazone measurement in plasma was simple, sensitive and employed a commercially available IS.